Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of December 2021.
Pharmaceuticals
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: Eliminating Barriers to Opioid Use Disorder Treatment Eliminating Barriers to Opioid Use Disorder Treatment
We know how to prevent overdose deaths, and yet, the majority of individuals with opioid use disorder lack access to the standard of care treatment.
-
Read more: Washington Psilocybin Bill Would Legalize Supported Adult Use Washington Psilocybin Bill Would Legalize Supported Adult Use
On Tuesday, Washington State legislators filed a bill that would legalize the supported adult use of psilocybin by people 21 years of age and older.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of November 2021.
-
Read more: Addressing IP Barriers in the Context of a Pandemic Treaty Addressing IP Barriers in the Context of a Pandemic Treaty
Tackling the question of how to address the needs for sharing scientific research is fundamental to any pandemic treaty discussion.
-
Read more: Leverage COVID-19 Frameworks to Prepare for the Next Pandemic Leverage COVID-19 Frameworks to Prepare for the Next Pandemic
How should scientists, policy makers, and governments balance efforts to address the current pandemic with initiatives to prevent the next one?
-
Read more: HHS’ New Prescription Drug and Health Care Spending Rule HHS’ New Prescription Drug and Health Care Spending Rule
A new interim final rule requires health insurance plans and issuers on the marketplace to report data on prescription drug and health care spending.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of October 2021.
-
Read more: What Democrats’ Drug Pricing Plan Means for Consumers What Democrats’ Drug Pricing Plan Means for Consumers
The new drug pricing plan creates protections against out-of-pocket costs for seniors with Medicare Part D benefits and people who take insulin.
-
Read more: The Paradoxical Legal Treatment of Preventive Medicine The Paradoxical Legal Treatment of Preventive Medicine
Despite its salubrious aim, stigma, shame, and fear often are attached to the use of preventative care.
